Current：Home > ContactNew drugs. Cheaper drugs. Why not both? -Visionary Wealth Guides
New drugs. Cheaper drugs. Why not both?
NovaQuant Quantitative Think Tank Center View
Date：2025-04-07 02:44:19
Here's the argument: Americans pay loads for drugs. That motivates and funds pharmaceutical companies' research and development for better drugs. The fear is that if you lower the cost of drugs you might hurt overall innovation.
Today on the show, we speak with a health economist who argues that's not always true. In fact, she says there are a bunch of policies that could help bring down drug prices without stifling innovation.
Music by Drop Electric. Find us: Twitter / Facebook / Newsletter.
Subscribe to our show on Apple Podcasts, Spotify, Pocket Casts and NPR One.
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
veryGood！ (9943)
Related
- Hackers hit Rhode Island benefits system in major cyberattack. Personal data could be released soon
- The story of Monopoly and American capitalism
- To all the econ papers I've loved before
- Meta allows Donald Trump back on Facebook and Instagram
- Louvre will undergo expansion and restoration project, Macron says
- What tracking one Walmart store's prices for years taught us about the economy
- An otter was caught stealing a surfboard in California. It was not the first time she's done it.
- U.S. files second antitrust suit against Google's ad empire, seeks to break it up
- Intel's stock did something it hasn't done since 2022
- Thom Browne's win against Adidas is also one for independent designers, he says
Ranking
- Travis Hunter, the 2
- Global Climate Panel’s Report: No Part of the Planet Will be Spared
- What tracking one Walmart store's prices for years taught us about the economy
- Former Broadway actor James Beeks acquitted of Jan. 6 charges
- Juan Soto praise of Mets' future a tough sight for Yankees, but World Series goal remains
- Former Broadway actor James Beeks acquitted of Jan. 6 charges
- Tom Cruise's stunts in Mission: Impossible — Dead Reckoning Part One presented new challenges, director says
- The story of Monopoly and American capitalism
Recommendation
Pressure on a veteran and senator shows what’s next for those who oppose Trump
Warming Trends: Increasing Heat is Dangerous for Pilgrims, Climate Warnings Painted on Seaweed and Many Plots a Global Forest Make
Saying goodbye to Pikachu and Ash, plus how Pokémon changed media forever
UN Report: Despite Falling Energy Demand, Governments Set on Increasing Fossil Fuel Production
Macy's says employee who allegedly hid $150 million in expenses had no major 'impact'
US Forest Fires Threaten Carbon Offsets as Company-Linked Trees Burn
M&M's replaces its spokescandies with Maya Rudolph after Tucker Carlson's rants
Exploding California Wildfires Rekindle Debate Over Whether to Snuff Out Blazes in Wilderness Areas or Let Them Burn